Authors
Loading...
The study demonstrates YTHDF1's regulation of LRP5 and Wnt-β-catenin, promoting HCC progression, suggesting a new therapeutic target.
Gu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: